GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » Receivables Turnover

Parenteral Drugs (India) (BOM:524689) Receivables Turnover : 0.00 (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Parenteral Drugs (India)'s Revenue for the three months ended in Mar. 2022 was ₹17.73 Mil. Parenteral Drugs (India)'s average Accounts Receivable for the three months ended in Mar. 2022 was ₹0.00 Mil.


Parenteral Drugs (India) Receivables Turnover Historical Data

The historical data trend for Parenteral Drugs (India)'s Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) Receivables Turnover Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.85 8.73 - - -

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Parenteral Drugs (India)'s Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parenteral Drugs (India)'s Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s Receivables Turnover falls into.



Parenteral Drugs (India) Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Parenteral Drugs (India)'s Receivables Turnover for the fiscal year that ended in Mar. 2022 is calculated as

Receivables Turnover (A: Mar. 2022 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2022 ) / ((Accounts Receivable (A: Mar. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count )
=84.963 / ((0 + 0) / 1 )
=84.963 / 0
=N/A

Parenteral Drugs (India)'s Receivables Turnover for the quarter that ended in Mar. 2022 is calculated as

Receivables Turnover (Q: Mar. 2022 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2022 ) / ((Accounts Receivable (Q: Dec. 2021 ) + Accounts Receivable (Q: Mar. 2022 )) / count )
=17.731 / ((0 + 0) / 1 )
=17.731 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parenteral Drugs (India)  (BOM:524689) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Parenteral Drugs (India) Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Parenteral Drugs (India) (BOM:524689) Business Description

Traded in Other Exchanges
N/A
Address
Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines